BR112013019280A2 - composições wnt e métodos para sua utilização - Google Patents
composições wnt e métodos para sua utilizaçãoInfo
- Publication number
- BR112013019280A2 BR112013019280A2 BR112013019280A BR112013019280A BR112013019280A2 BR 112013019280 A2 BR112013019280 A2 BR 112013019280A2 BR 112013019280 A BR112013019280 A BR 112013019280A BR 112013019280 A BR112013019280 A BR 112013019280A BR 112013019280 A2 BR112013019280 A2 BR 112013019280A2
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- wnt compositions
- wnt
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Marine Sciences & Fisheries (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161462130P | 2011-01-28 | 2011-01-28 | |
| PCT/US2012/022761 WO2012103360A2 (en) | 2011-01-28 | 2012-01-26 | Wnt compositions and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112013019280A2 true BR112013019280A2 (pt) | 2017-03-21 |
Family
ID=46581406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013019280A BR112013019280A2 (pt) | 2011-01-28 | 2012-01-26 | composições wnt e métodos para sua utilização |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20140200179A1 (pt) |
| EP (1) | EP2667889A4 (pt) |
| JP (1) | JP2014506568A (pt) |
| KR (1) | KR20140035337A (pt) |
| CN (1) | CN103501799A (pt) |
| AU (1) | AU2012211277A1 (pt) |
| BR (1) | BR112013019280A2 (pt) |
| CA (1) | CA2825211A1 (pt) |
| SG (1) | SG192182A1 (pt) |
| WO (1) | WO2012103360A2 (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010124365A1 (en) | 2009-04-27 | 2010-11-04 | Ottawa Hospital Research Institute | Compositions and methods for modulating stem cells and uses thereof |
| SG11201400668SA (en) * | 2011-09-16 | 2014-04-28 | Fate Therapeutics Inc | Wnt compositions and therapeutic uses of such compositions |
| CA2848851C (en) | 2011-09-16 | 2020-09-22 | Ottawa Hospital Research Institute | Wnt7a compositions and methods of using the same |
| CN111193048A (zh) | 2012-04-02 | 2020-05-22 | 水吉能公司 | 燃料电池模块及其启动、关闭和重新启动的方法 |
| WO2014194267A2 (en) * | 2013-05-30 | 2014-12-04 | The Board Of Trustees Of The Leland Stanford Junior University | Wnt peptide pharmacophore compositions and methods of use thereof |
| CA2980113A1 (en) * | 2014-03-28 | 2015-10-01 | Ottawa Hospital Research Institute | Wnt induced motility and enhanced engraftment of cells |
| CA2959045A1 (en) | 2014-09-12 | 2016-03-17 | The University Of Washington | Wnt signaling agonist molecules |
| JP6399563B2 (ja) * | 2014-12-24 | 2018-10-03 | 国立大学法人大阪大学 | Ｗｎｔ蛋白質の製造方法および保存方法 |
| JP7150604B2 (ja) * | 2016-01-28 | 2022-10-11 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 無血清合成のためのｗｎｔ組成物及び方法 |
| JP7216024B2 (ja) * | 2017-05-31 | 2023-01-31 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 腫瘍細胞におけるＷｎｔシグナル伝達と拮抗するポリペプチド |
| CN117946267A (zh) | 2017-12-19 | 2024-04-30 | 瑟罗泽恩奥普瑞汀公司 | 抗卷曲蛋白抗体和使用方法 |
| CA3085782A1 (en) | 2017-12-19 | 2019-06-27 | Surrozen, Inc. | Wnt surrogate molecules and uses thereof |
| CA3085785A1 (en) | 2017-12-19 | 2019-06-27 | Surrozen, Inc. | Anti-lrp5/6 antibodies and methods of use |
| US20210317413A1 (en) * | 2018-07-16 | 2021-10-14 | The Board Of Trustees Of The Leland Stanford Junior University | Frizzled specific wnt agonists and antagonists |
| CN110305209B (zh) * | 2019-07-09 | 2022-09-13 | 福建医科大学附属第一医院 | 用于治疗恶性肿瘤的多肽及其作为疫苗的用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7374760B2 (en) * | 2003-05-15 | 2008-05-20 | The University Of Chicago | Methods and compositions for nerve regeneration |
| WO2006036175A2 (en) * | 2004-09-21 | 2006-04-06 | Rhode Island Hospital, A Lifespan-Partner | Wnt proteins and detection and treatment of cancer |
| WO2008109119A2 (en) * | 2007-03-05 | 2008-09-12 | The Board Of Trustees Of The Leland Stanford Junior University | Wnt compositions and methods of use thereof |
| WO2010014948A1 (en) * | 2008-08-01 | 2010-02-04 | The University Of Utah Research Foundation | Methods of treatment using wnt inhibitors |
| CA2748716A1 (en) * | 2008-12-31 | 2010-07-08 | The Regents Of The University Of California | Dominant negative wnt2 compositions and methods of use |
-
2012
- 2012-01-26 SG SG2013057302A patent/SG192182A1/en unknown
- 2012-01-26 JP JP2013551343A patent/JP2014506568A/ja active Pending
- 2012-01-26 AU AU2012211277A patent/AU2012211277A1/en not_active Abandoned
- 2012-01-26 US US13/982,184 patent/US20140200179A1/en not_active Abandoned
- 2012-01-26 EP EP12738949.2A patent/EP2667889A4/en not_active Withdrawn
- 2012-01-26 CN CN201280014977.8A patent/CN103501799A/zh active Pending
- 2012-01-26 KR KR1020137022560A patent/KR20140035337A/ko not_active Application Discontinuation
- 2012-01-26 WO PCT/US2012/022761 patent/WO2012103360A2/en active Application Filing
- 2012-01-26 CA CA2825211A patent/CA2825211A1/en not_active Abandoned
- 2012-01-26 BR BR112013019280A patent/BR112013019280A2/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012211277A1 (en) | 2013-08-29 |
| CA2825211A1 (en) | 2012-08-02 |
| SG192182A1 (en) | 2013-08-30 |
| KR20140035337A (ko) | 2014-03-21 |
| WO2012103360A2 (en) | 2012-08-02 |
| EP2667889A2 (en) | 2013-12-04 |
| WO2012103360A3 (en) | 2012-10-11 |
| US20140200179A1 (en) | 2014-07-17 |
| EP2667889A4 (en) | 2014-08-06 |
| JP2014506568A (ja) | 2014-03-17 |
| CN103501799A (zh) | 2014-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013019280A2 (pt) | composições wnt e métodos para sua utilização | |
| BR112014005744A2 (pt) | composições de peptídeo glucagon-like-2 e métodos para sua produção e utilização | |
| CR20130677A (es) | FORMULACIÓN PARA ANTICUERPO ANTI-a4ß7 | |
| CL2014003386A1 (es) | Métodos y composiciones para producción de biometano | |
| DK2763665T3 (da) | Antimikrobielle sammensætninger og fremgangsmåder til anvendelse deraf | |
| BRDI7106210S (pt) | Configuração aplicada para lâmina para microscópio | |
| CO6801648A2 (es) | Formulación para anticuerpo anti-α4β7 | |
| BR112013019732A2 (pt) | composições e métodos para tratamento de doenças cardiovasculares | |
| BR112013032426A2 (pt) | composições probióticas e métodos | |
| BR112013022112A2 (pt) | composição | |
| BR112013022102A2 (pt) | composição | |
| DK2686017T3 (da) | Oftalmisk sammensætning | |
| BR112014004395A2 (pt) | composição | |
| CO6920293A2 (es) | Compuestos antibaterianos y método para su uso | |
| BR112014010450A2 (pt) | composição e método | |
| BR112013014644A2 (pt) | composição farmacêutica e complexo | |
| BR112013006131A2 (pt) | inibidores de notum pectinacetilesterase e métodos para sua utilização | |
| BR112013033808A2 (pt) | composição | |
| BR112013012583A2 (pt) | composições de limpeza diluíveis e métodos para utilização | |
| BR112014022694A2 (pt) | novos métodos e composições para o tratamento de doença | |
| CO6781494A2 (es) | Composición lubricante y método para su preparación | |
| BR112014010860A2 (pt) | composição e método | |
| BR112014007030A2 (pt) | composição | |
| FR2974083B1 (fr) | Broyeur composteur et utilisation | |
| CO6920303A2 (es) | Preparación plaguicida y procedimiento para su preparación |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: application dismissed [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |